Is Neuroleptic Malignant Syndrome the Deadly Drugging of Dementia you Need to Know About?

In recent years, there has been an alarming rise in cases of neuroleptic malignant syndrome (NMS) among patients with dementia. This deadly condition, characterized by a severe reaction to certain medications, can have devastating consequences for those affected. In this article, we will explore the dangers of NMS and its connection with dementia, shedding light on a critical issue that requires attention from medical professionals and caregivers alike.

Understanding Neuroleptic Malignant Syndrome

Neuroleptic malignant syndrome is a rare but potentially fatal condition that can occur as a side effect of antipsychotic medications commonly used to manage behavioral symptoms in individuals with dementia. Symptoms of NMS often include hyperthermia (abnormally high body temperature), muscle rigidity, altered mental status, autonomic dysfunction, and increased levels of creatine kinase in the blood.

While the exact causes of NMS are not yet fully understood, it is believed that a combination of genetic factors, individual susceptibility, and the use of certain medications contributes to the onset of this condition. The underlying mechanisms involve dysregulation of dopamine neurotransmission and disturbances in thermoregulatory centers of the brain.

Neuroleptic Malignant Syndrome: Deadly Drugging of Dementia

by Victoria Allen (Kindle Edition)

4.6 out of 5

Language	:	English
File size	:	2475 KB
Text-to-Speech	:	Enabled
Screen Reader	:	Supported
Enhanced typesetting	:	Enabled
Print length	:	295 pages
Lending	:	Enabled

FREE

The Connection with Dementia

Dementia, a progressive neurological disorder that affects cognition and behavior, is often accompanied by various behavioral symptoms such as agitation, aggression, and psychosis. In an attempt to manage these symptoms, healthcare providers frequently prescribe antipsychotic medications. However, studies have shown that individuals with dementia who receive these medications have an increased risk of developing NMS.

The vulnerable nature of dementia patients makes them more susceptible to the adverse effects of antipsychotics. Additionally, it is essential to acknowledge that the off-label use of antipsychotics in dementia is widespread, as these medications are primarily approved for treating psychiatric conditions, not dementia-related symptoms. This inappropriate usage further heightens the risk of NMS development.

The Importance of Early Detection

Recognizing the early signs and symptoms of NMS is crucial to prevent severe complications and minimize the potential impact on patients' health. When caregivers and healthcare professionals are vigilant, they can identify the condition promptly and take appropriate actions, such as discontinuing the offending medication and providing supportive care.

Common warning signs that warrant attention include fever, muscle stiffness, mental status changes, tachycardia, and dyspnea. Immediate medical attention should be sought if these symptoms arise in individuals taking antipsychotics.

Preventing NMS in Dementia Patients

To reduce the risk of neuroleptic malignant syndrome in individuals with dementia, comprehensive strategies must be implemented. First and foremost, healthcare providers need to exercise caution when prescribing antipsychotics to this vulnerable population. Alternative therapies and non-pharmacological interventions should be considered as first-line approaches whenever possible.

Regular monitoring of patients receiving antipsychotics is essential to detect any early signs of NMS. This includes frequent assessments of body temperature, evaluation of muscle stiffness, mental status checks, and monitoring of cardiac and respiratory functions. Caregivers should also be educated on these warning signs to ensure timely intervention.

The Road to Improved Safety and Care

The rising incidence of neuroleptic malignant syndrome among dementia patients highlights the need for improved medication safety and care practices. Healthcare professionals, including physicians, nurses, and pharmacists, must stay updated on the latest research and guidelines concerning medication use in dementia. Collaborative efforts are necessary to develop standardized protocols and policies that prioritize patient safety and improve the quality of care.

Caregivers and family members are equally responsible for advocating on behalf of their loved ones. By raising awareness about the risks associated with antipsychotics and encouraging open communication with healthcare providers, they can contribute to a safer healthcare environment for individuals with dementia.

Neuroleptic malignant syndrome poses a grave threat to individuals with dementia who are treated with antipsychotic medications. By understanding the risks and working together, medical professionals and caregivers can take proactive steps to identify, prevent, and manage NMS, ultimately improving the overall well-being and safety of dementia patients.

Neuroleptic Malignant Syndrome: Deadly Drugging of Dementia

by Victoria Allen (Kindle Edition)

4.6 out of 5

Language	:	English
File size	:	2475 KB
Text-to-Speech	:	Enabled
Screen Reader	:	Supported
Enhanced typesetting	:	Enabled
Print length	:	295 pages
Lending	:	Enabled

FREE

A little-known, physical phenomena and a much, misunderstood illness that can turn a person into a vegetative state, which is often misdiagnosed and unrecognised. A potentially lethal condition being inflicted on the human body, by the very substances claiming to “help”. Visit www.neurolepticmalignantsyndrome.info
Could it be your loved one next? Will you recognise the syndrome before it is too late?
Set on the Isle of Man, this book explores the circumstances surrounding the infliction and provides much more understanding of this induced illness, that can turn a human into a helpless, mute, paralysed, state of oblivion.
For Isle of Man residents, the book provides an insight into the “Independent Review Body”, hospital complaints finale. Readers can come to their own s.
Most importantly, the book aims to provide clarity, both physically and medically, on this puzzling and deadly, manmade condition.
Neuroleptic Malignant Syndrome should NOT be happening to dementia patients.
A truly terrifying narrative account of one family’s encounter.